{"nct_id":"NCT03134222","title":"Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)","status":"COMPLETED","status_verified_date":"2020-06","start_date":"2017-05-24","start_date_type":"ACTUAL","primary_completion_date":"2019-03-13","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}